Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET-stratified R-CHOP vs R-DICEP/R-BEAM/ASCT in DLBCL
NCT00530179Phase 2Completed
- Sponsor
- American Health Staffing Group
- Start
- Jul 2007
- Primary completion
- Feb 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by American Health Staffing Group. Started Jul 2007; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00530179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530179.